FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1869363482> ?p ?o ?g. }

• W1869363482 endingPage "711" @default.
• W1869363482 startingPage "705" @default.
• W1869363482 abstract "To assess results with twice-daily high-dose radiotherapy (RT) for non-small-cell lung cancer (NSCLC).Between 1991 and 1998, 94 patients with unresectable NSCLC were prescribed > or = 73.6 Gy via accelerated fractionation. Fifty were on a phase II protocol (P group); 44 were similarly treated off-protocol (NP group). The clinical target volume received 45 Gy at 1.25 Gy bid (6-hour interval). The gross target volume received 1.6 Gy bid to 73.6 to 80 Gy over 4.5 to 5 weeks using a concurrent boost technique. Overall survival (OS) and local progression-free survival (LPFS) were calculated by the Kaplan-Meier method. Median follow-up durations for surviving P and NP patients were 67 and 16 months, respectively.Total doses received were > or = 72 Gy in 97% of patients. The median OS by stage was 34, 13, and 12 months for stages I/II, IIIa, and IIIb, respectively. LPFS was significantly longer for patients with T1 lesions (median, 43 months) versus T2-4 (median, 7 to 10 months; P =.01). Results were similar in the P and NP groups. Acute grade > or = 3 toxicity included esophagus (14 patients; 15%), lung (three patients; 3% [one grade 5]), and skin (four patients; 4%). Grade > or = 3 late toxicity in 86 assessable patients included esophagus (three patients; 3%), lung (15 patients; 17% [three grade 5]), skin (five patients; 6%), heart (two patients; 2%), and nerve (one patient; 1%).This regimen yielded favorable survival results, particularly for T1 lesions. Acute grade > or = 3 toxicity seems greater than for conventional RT, though most patients recovered. Late grade > or = 3 pulmonary toxicity occurred in 17%. Because of continued locoregional recurrences, we are currently using doses > or = 86 Gy." @default.
• W1869363482 created "2016-06-24" @default.
• W1869363482 creator A5002149968 @default.
• W1869363482 creator A5009526617 @default.
• W1869363482 creator A5011124954 @default.
• W1869363482 creator A5011590188 @default.
• W1869363482 creator A5049815757 @default.
• W1869363482 creator A5067403868 @default.
• W1869363482 creator A5069874449 @default.
• W1869363482 creator A5085651347 @default.
• W1869363482 creator A5086702989 @default.
• W1869363482 date "2001-02-01" @default.
• W1869363482 modified "2023-09-27" @default.
• W1869363482 title "73.6 Gy and Beyond: Hyperfractionated, Accelerated Radiotherapy for Non–Small-Cell Lung Cancer" @default.
• W1869363482 cites W104740838 @default.
• W1869363482 cites W1831241863 @default.
• W1869363482 cites W1930978022 @default.
• W1869363482 cites W1993858850 @default.
• W1869363482 cites W2010733840 @default.
• W1869363482 cites W2014145691 @default.
• W1869363482 cites W2021716162 @default.
• W1869363482 cites W2021775131 @default.
• W1869363482 cites W2026788229 @default.
• W1869363482 cites W2031555443 @default.
• W1869363482 cites W2033366141 @default.
• W1869363482 cites W2045724824 @default.
• W1869363482 cites W2056012403 @default.
• W1869363482 cites W2057616211 @default.
• W1869363482 cites W2138310931 @default.
• W1869363482 cites W2155053061 @default.
• W1869363482 cites W2160234796 @default.
• W1869363482 cites W2165046000 @default.
• W1869363482 cites W2179742682 @default.
• W1869363482 cites W2226077283 @default.
• W1869363482 cites W4293241248 @default.
• W1869363482 doi "https://doi.org/10.1200/jco.2001.19.3.705" @default.
• W1869363482 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11157021" @default.
• W1869363482 hasPublicationYear "2001" @default.
• W1869363482 type Work @default.
• W1869363482 sameAs 1869363482 @default.
• W1869363482 citedByCount "69" @default.
• W1869363482 countsByYear W18693634822012 @default.
• W1869363482 countsByYear W18693634822013 @default.
• W1869363482 countsByYear W18693634822014 @default.
• W1869363482 countsByYear W18693634822015 @default.
• W1869363482 countsByYear W18693634822016 @default.
• W1869363482 countsByYear W18693634822020 @default.
• W1869363482 crossrefType "journal-article" @default.
• W1869363482 hasAuthorship W1869363482A5002149968 @default.
• W1869363482 hasAuthorship W1869363482A5009526617 @default.
• W1869363482 hasAuthorship W1869363482A5011124954 @default.
• W1869363482 hasAuthorship W1869363482A5011590188 @default.
• W1869363482 hasAuthorship W1869363482A5049815757 @default.
• W1869363482 hasAuthorship W1869363482A5067403868 @default.
• W1869363482 hasAuthorship W1869363482A5069874449 @default.
• W1869363482 hasAuthorship W1869363482A5085651347 @default.
• W1869363482 hasAuthorship W1869363482A5086702989 @default.
• W1869363482 hasConcept C126322002 @default.
• W1869363482 hasConcept C141071460 @default.
• W1869363482 hasConcept C146357865 @default.
• W1869363482 hasConcept C151730666 @default.
• W1869363482 hasConcept C155806632 @default.
• W1869363482 hasConcept C2776256026 @default.
• W1869363482 hasConcept C2777714996 @default.
• W1869363482 hasConcept C2777819096 @default.
• W1869363482 hasConcept C2781413609 @default.
• W1869363482 hasConcept C29730261 @default.
• W1869363482 hasConcept C509974204 @default.
• W1869363482 hasConcept C71924100 @default.
• W1869363482 hasConcept C86803240 @default.
• W1869363482 hasConcept C90924648 @default.
• W1869363482 hasConceptScore W1869363482C126322002 @default.
• W1869363482 hasConceptScore W1869363482C141071460 @default.
• W1869363482 hasConceptScore W1869363482C146357865 @default.
• W1869363482 hasConceptScore W1869363482C151730666 @default.
• W1869363482 hasConceptScore W1869363482C155806632 @default.
• W1869363482 hasConceptScore W1869363482C2776256026 @default.
• W1869363482 hasConceptScore W1869363482C2777714996 @default.
• W1869363482 hasConceptScore W1869363482C2777819096 @default.
• W1869363482 hasConceptScore W1869363482C2781413609 @default.
• W1869363482 hasConceptScore W1869363482C29730261 @default.
• W1869363482 hasConceptScore W1869363482C509974204 @default.
• W1869363482 hasConceptScore W1869363482C71924100 @default.
• W1869363482 hasConceptScore W1869363482C86803240 @default.
• W1869363482 hasConceptScore W1869363482C90924648 @default.
• W1869363482 hasIssue "3" @default.
• W1869363482 hasLocation W18693634821 @default.
• W1869363482 hasLocation W18693634822 @default.
• W1869363482 hasOpenAccess W1869363482 @default.
• W1869363482 hasPrimaryLocation W18693634821 @default.
• W1869363482 hasRelatedWork W1586374228 @default.
• W1869363482 hasRelatedWork W1963579780 @default.
• W1869363482 hasRelatedWork W2003938723 @default.
• W1869363482 hasRelatedWork W2047967234 @default.
• W1869363482 hasRelatedWork W2118496982 @default.
• W1869363482 hasRelatedWork W2364998975 @default.
• W1869363482 hasRelatedWork W2369162477 @default.
• W1869363482 hasRelatedWork W2439875401 @default.

• next